Autonomic symptom burden in patients with advanced dementia with Lewy bodies is linked to worsening cognitive fluctuations.

Dr. Guruprasad Hosurkar, a leading neurologist, receives the prestigious MDSI Fellowship Award for his exceptional ...

In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Mary-Elizabeth Patti, MD, and ...

While negative experiences during early life are known to disrupt gut-brain axis development, the mechanisms linking ...

Agreement with second leading group purchasing organization (GPO), effective June 1, 2026, provides access to approximately 17 million additional ...

For years, the working theory was straightforward: SARS-CoV-2 triggers lasting inflammation throughout the brain, and that ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces initial ...

Sleep breathing disorders (SBDs)—including obstructive sleep apnoea, central sleep apnoea and sleep-related hypoventilation syndromes—represent a major yet under-recognised contributor to global ...

Chronic pain, burnout, poor sleep, inflammation, and nervous system overload are fueling a growing obsession with recovery, ...

A case report presented at AAPA 2026 involves a 53-year-old man who presents with acute bilateral facial paralysis.

But the landscape of personal health tracking has quietly shifted over the last few years. Smartwatches no longer just count steps. … Most of us are familiar with smartwatches buzzing when we sit too ...

Foralumab is the first intranasal immune modulator in clinical trials for patients with Multiple System AtrophyBOSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiz ...